title: Case of hypophysitis caused by nivolumab.
authors.affiliation: Department of Dermatology, Saitama Cancer Center, Saitama, Japan.
authors.forename: Masashi
authors.initials: M
authors.lastname: Ishikawa
authors.affiliation: Department of Dermatology, Saitama Cancer Center, Saitama, Japan.
authors.forename: Kohei
authors.initials: K
authors.lastname: Oashi
mesh_terms: D000309:Adrenal Insufficiency / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000855:Anorexia / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003228:Conjunctiva; D003606:Dacarbazine / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D000072659:Hypophysitis / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging; D007037:Hypothyroidism / Q000139:chemically induced; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008279:Magnetic Resonance Imaging; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D063806:Myalgia / Q000209:etiology; D009325:Nausea / Q000209:etiology; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D028761:Withholding Treatment
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab; D003606:Dacarbazine; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone